July 28, 2016 3:36 AM ET

Healthcare Equipment and Supplies

Company Overview of Xagenic Inc.

Company Overview

Xagenic Inc., a molecular diagnostics company, develops The Xagenic X1 platform, a diagnostic system for use in a clinician’s office. Its Xagenic X1 platform allows users to perform lab-quality molecular diagnostic tests in the physician office. The company also provides AuRA technology, a solution based on ultrasensitive microelectrode arrays. Xagenic Inc. was founded in 2010 and is based in Toronto, Canada with an additional office in San Francisco, California.

55 York Street

Suite 1000

Toronto, ON M5J 1R7


Founded in 2010





Key Executives for Xagenic Inc.

Chief Executive Officer, President and Director
Age: 50
Founder, Chief Technology Officer and Director
Chief Financial Officer
Vice President of Operations
Age: 50
Chief Medical Officer
Compensation as of Fiscal Year 2016.

Xagenic Inc. Key Developments

Xagenic Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 10:00 AM

Xagenic Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 10:00 AM. Venue: Westin Grand Central, New York, New York, United States. Speakers: Ihor Boszko, Vice President of Business Development, Timothy I. Still, Chief Executive Officer, President and Director.

Xagenic Appoints Randall Wilhoite as Vice President of Operations

Xagenic announced that Randall Wilhoite has joined the company as Vice President of Operations. Wilhoite will oversee manufacturing and operations to ensure the company’s commercial objectives for the Xagenic X1 platform are met. Wilhoite brings a wealth of operational experience in vitro diagnostics to this newly-established role at Xagenic, most recently from Siemens Healthcare Diagnostics, where he directed point of care manufacturing. Prior to Siemens, Wilhoite held senior operations, logistics and supply chain roles at two companies – Oscient Pharmaceuticals Inc. and Anika Therapeutics Inc. He began his career in the diagnostics division of Abbott Laboratories Inc., where he spent 15 years in various roles within operations and received several awards for improved efficiency and cost reduction.

Xagenic Names Tom Waddell as Vice President of Product Development

Xagenic announced that Tom Waddell, Ph.D., MBA has joined the company as a Vice President leading its product development team. Waddell brings a decade of diagnostic research and development experience to Xagenic from Pro-Lab Diagnostics and most recently in the Assay Research Group of Abbott Point of Care. At Abbott, Waddell managed a team of scientists and engineers developing new product prototypes and honing the manufacturing processes associated with the production of these new tests.

Similar Private Companies By Industry

Company Name Region
A.R. Medicom, Inc. Americas
ABK Biomedical Inc. Americas
Adaptaide Inc. Americas
Adjuvant Therapeutics Inc. Americas
Advanced Bioelectric Corp. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xagenic Inc., please visit www.xagenic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.